{
    "clinical_study": {
        "@rank": "137752", 
        "arm_group": [
            {
                "arm_group_label": "Probiotics F19", 
                "arm_group_type": "Experimental", 
                "description": "F19 in an infant formula"
            }, 
            {
                "arm_group_label": "Whey protein concentrate", 
                "arm_group_type": "Experimental", 
                "description": "Whey protein concentrate in an infant formula"
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate the effects of feeding an infant formula containing L. paracasei ssp. paracasei\n      strain F19 or Whey Protein Concentrate."
        }, 
        "brief_title": "Feeding Infant Formula With Added Probiotics and Whey Protein Concentrate", 
        "completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Focus on Healthy Infants", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria (formula-fed group):\n\n        healthy infants of mothers who could not or voluntarily resigned completely from\n        breast-feeding at infant age 14 plus/minus 3 days\n\n        Inclusion criteria (breast-fed group):\n\n        healthy infants exclusively breast-fed from birth and mothers intending to breastfeed >80%\n        until at least 5th month of age (meaning through the 4th month of age).\n\n        Inclusion criteria (all infants):\n\n        delivered between 37 and 42 weeks of gestation birth weight >2500 g and <4000 g parent or\n        the subject's legal representative speak and understand Chinese\n\n        Exclusion criteria (formula-fed group):\n\n        fully or partially breast-fed infants infants breast-fed >20%\n\n        Exclusion criteria (breast-fed group):\n\n        infants fed >20% infant formula\n\n        Exclusion criteria (all infants):\n\n        malformations, handicaps or congenital diseases that could affect normal  feeding or\n        growth treatment with antibiotics"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "2 Weeks", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "800", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 12, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01755481", 
            "org_study_id": "327727-2"
        }, 
        "intervention": [
            {
                "arm_group_label": "Probiotics F19", 
                "intervention_name": "Probiotic", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Whey protein concentrate", 
                "intervention_name": "Whey protein concentrate", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 5, 2013", 
        "location": {
            "contact": {
                "email": "ympeng99@yahoo.com.cn", 
                "last_name": "Yongmei Peng, M.D., Ph.D.,"
            }, 
            "contact_backup": {
                "email": "xiaonan6189@yahoo.com", 
                "last_name": "Xiaonan Li, M.D., Ph.D.,"
            }, 
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China"
                }, 
                "name": "Department of Child Health Care, Children's Hospital, Fudan University"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Feeding Infant Formula With Added Probiotics and Whey Protein Concentrate", 
        "overall_contact": {
            "email": "ympeng99@yahoo.com", 
            "last_name": "Yongmei Peng, M.D., Ph.D.,"
        }, 
        "overall_contact_backup": {
            "email": "xiaonan6189@yahoo.com", 
            "last_name": "Xiaonan Li, M.D., Ph.D.,"
        }, 
        "overall_official": {
            "affiliation": "Children's Hospital, Fudan University, Shanghai, China", 
            "last_name": "Yongmei Peng, M.D., Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Infections episodes (gastrointestinal and upper and lower respiratory infections)", 
            "safety_issue": "No", 
            "time_frame": "4 yrs"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01755481"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Arla Foods", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Arla Foods", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}